More men may get, die from cancer by 2050

The rate of cancer incidence and mortality among men may be projected to rise significantly by 2050.

In a study published in Cancer, investigators used the 2022 GLOBOCAN estimates to analyze the data of 30 cancer types among men in 185 countries.

The investigators identified 10.3 million and 5.4 million new cancer cases and cancer-related deaths among men in 2022. Prostate cancer was the most common type of new diagnosis, whereas lung cancer was the leading cause of cancer-related mortality.

Between 2022 and 2050, the incidence of cancer was estimated to increase by 84% and the cancer-related mortality rate was predicted to increase by 93%.

The findings represented a critical need for targeted interventions and global cooperation to address the disproportionate burden of cancer among men — particularly in countries and regions with a low human development index.

Read more: Cancer

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.